Daewon Pharmaceutical Co., Ltd. (KRX:003220)
10,420
+160 (1.56%)
At close: Mar 20, 2026
-25.73% (1Y)
| Market Cap | 223.34B -27.9% |
| Revenue (ttm) | 590.70B -0.5% |
| Net Income | -16.04B |
| EPS | -748.20 |
| Shares Out | 21.43M |
| PE Ratio | n/a |
| Forward PE | 29.35 |
| Dividend | 300.00 (2.88%) |
| Ex-Dividend Date | Dec 29, 2025 |
| Volume | 20,732 |
| Average Volume | 40,786 |
| Open | 10,270 |
| Previous Close | 10,260 |
| Day's Range | 10,270 - 10,460 |
| 52-Week Range | 10,110 - 14,700 |
| Beta | 0.18 |
| RSI | 39.65 |
| Earnings Date | Mar 25, 2026 |